Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Flaherty

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Journal of Animal Physiology and Animal Nutrition|November 25, 2003
Effect of dietary protein on lean body wasting in dogs: correlation between loss of lean mass and markers of proteasome-dependent proteolysisJ J Wakshlag, S C Barr, G A Ordway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcomeJeffrey A Sosman, Joseph M Unger, P-Y Liu, et al.
Cancer|January 1, 1995
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanomaM K Wallack, M Sivanandham, C M Balch, et al.
Cancer|September 25, 2014
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933Sylvia M Lee, James Moon, Bruce G Redman, et al.
Cancer|April 2, 2011
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430Jeffrey A Sosman, James Moon, Ralph J Tuthill, et al.
Veterinary Therapeutics : Research in Applied Veterinary Medicine|November 26, 2002
Effects of exercise on canine skeletal muscle proteolysis: an investigation of the ubiquitin-proteasome pathway and other metabolic markersJoseph J Wakshlag, Francis A Kallfelz, Stephen C Barr, et al.
Investigational New Drugs|May 11, 2002
A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group studyRobert P Whitehead, Joseph M Unger, Lawrence E Flaherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group studyK A Margolin, P Y Liu, L E Flaherty, et al.
Cancer|November 18, 2009
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508Joseph I Clark, James Moon, Laura F Hutchins, et al.
Journal of the National Cancer Institute|November 15, 1995
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group studyF L Meyskens, K J Kopecky, C W Taylor, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Journal of Animal Physiology and Animal Nutrition|November 25, 2003
Effect of dietary protein on lean body wasting in dogs: correlation between loss of lean mass and markers of proteasome-dependent proteolysisJ J Wakshlag, S C Barr, G A Ordway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcomeJeffrey A Sosman, Joseph M Unger, P-Y Liu, et al.
Cancer|January 1, 1995
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanomaM K Wallack, M Sivanandham, C M Balch, et al.
Cancer|September 25, 2014
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933Sylvia M Lee, James Moon, Bruce G Redman, et al.
Cancer|April 2, 2011
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430Jeffrey A Sosman, James Moon, Ralph J Tuthill, et al.
Veterinary Therapeutics : Research in Applied Veterinary Medicine|November 26, 2002
Effects of exercise on canine skeletal muscle proteolysis: an investigation of the ubiquitin-proteasome pathway and other metabolic markersJoseph J Wakshlag, Francis A Kallfelz, Stephen C Barr, et al.
Investigational New Drugs|May 11, 2002
A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group studyRobert P Whitehead, Joseph M Unger, Lawrence E Flaherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group studyK A Margolin, P Y Liu, L E Flaherty, et al.
Cancer|November 18, 2009
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508Joseph I Clark, James Moon, Laura F Hutchins, et al.
Journal of the National Cancer Institute|November 15, 1995
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group studyF L Meyskens, K J Kopecky, C W Taylor, et al.
Pageof 13